| Name | DOP1 leucine zipper like protein B |
| Description | Involved in cognition and embryonic pattern specification. Located in early endosome membrane. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n DOPEY2, also known as C21orf5, is an evolutionarily conserved member of the dopey family whose protein product contains highly conserved leucine zipper‐like domains. Studies in humans and model organisms have implicated this gene in key developmental processes. Notably, its expression is enriched in specific brain regions critical for learning and memory, where proper regulation appears essential for normal cortical lamination and neuronal differentiation. Overexpression in Down syndrome is correlated with altered brain morphogenesis and cognitive deficits, suggesting that DOPEY2 dosage imbalance contributes to the neurological features of the syndrome."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In addition to its role in neurodevelopment, DOPEY2 has been implicated in intracellular membrane trafficking. It is a component of a conserved MON2–DOPEY complex that participates in the formation and segregation of recycling endosomes and facilitates the endosome-to-Golgi transport of cargos such as Wntless."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, a circular RNA derived from DOPEY2 (circDOPEY2) has been shown to modulate apoptotic signaling and chemosensitivity in esophageal squamous cell carcinoma by acting as a scaffold that promotes the degradation of key RNA‐binding proteins, thereby impacting the translation of antiapoptotic factors."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Finally, genetic analyses have identified DOPEY2 as enriched in rare variants in patients with neurodevelopmental and neurodegenerative disorders, further supporting its role as a dosage-sensitive gene whose dysregulation may contribute to disease pathogenesis, including Alzheimer’s disease."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Mohammed Rachidi, Carmela Lopes, Maher Costantine, et al. "}, {"type": "b", "children": [{"type": "t", "text": "C21orf5, a new member of Dopey family involved in morphogenesis, could participate in neurological alterations and mental retardation in Down syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "DNA Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/dnares/dsi004"}], "href": "https://doi.org/10.1093/dnares/dsi004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16303751"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16303751"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Carmela Lopes, Zoubida Chettouh, Jean Maurice Delabar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The differentially expressed C21orf5 gene in the medial temporal-lobe system could play a role in mental retardation in Down syndrome and transgenic mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0006-291x(03)00867-2"}], "href": "https://doi.org/10.1016/s0006-291x(03"}, {"type": "t", "text": "00867-2) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12767918"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12767918"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "M Rachidi, C Lopes, A-L Delezoide, et al. "}, {"type": "b", "children": [{"type": "t", "text": "C21orf5, a human candidate gene for brain abnormalities and mental retardation in Down syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cytogenet Genome Res (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000087509"}], "href": "https://doi.org/10.1159/000087509"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16276086"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16276086"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Mohammed Rachidi, Carmela Lopes, Catherine Vayssettes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "New cerebellar phenotypes in YAC transgenic mouse in vivo library of human Down syndrome critical region-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2007.10.035"}], "href": "https://doi.org/10.1016/j.bbrc.2007.10.035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17963726"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17963726"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Shen-Bao Zhao, Neta Dean, Xiao-Dong Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MON2 Guides Wntless Transport to the Golgi through Recycling Endosomes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Struct Funct (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1247/csf.20012"}], "href": "https://doi.org/10.1247/csf.20012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32404555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32404555"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Zhenchuan Liu, Shaorui Gu, Kaiqin Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircRNA-DOPEY2 enhances the chemosensitivity of esophageal cancer cells by inhibiting CPEB4-mediated Mcl-1 translation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-021-02149-5"}], "href": "https://doi.org/10.1186/s13046-021-02149-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34781999"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34781999"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Eman Alhuzimi, Luis G Leal, Michael J E Sternberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Properties of human genes guided by their enrichment in rare and common variants."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.23377"}], "href": "https://doi.org/10.1002/humu.23377"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29197136"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29197136"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Shanker Swaminathan, Li Shen, Sungeun Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Alzheimer Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/156720512802455331"}], "href": "https://doi.org/10.2174/156720512802455331"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22486522"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22486522"}]}]}]}
|
| NCBI Gene ID | 9980 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
DOP1B has 2,321 functional associations with biological entities spanning 6 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 35 datasets.
Click the + buttons to view associations for DOP1B from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of DOP1B gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of DOP1B gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with DOP1B protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with DOP1B gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of DOP1B gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of DOP1B gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing DOP1B protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing DOP1B protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with DOP1B protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of DOP1B protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by DOP1B gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with DOP1B gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with DOP1B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving DOP1B gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving DOP1B gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing DOP1B protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing DOP1B protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of DOP1B gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of DOP1B gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by DOP1B gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of DOP1B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of DOP1B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of DOP1B gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of DOP1B gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by DOP1B gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of DOP1B gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of DOP1B gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving DOP1B protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of DOP1B gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of DOP1B gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of DOP1B gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of DOP1B gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of DOP1B gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of DOP1B protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with DOP1B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |